Flexible Payment Solutions
[UPDATE] On April 30th, 2018, the 9th US Circuit Court rejected a petition from the Hemp Industries Association, thus establishing the classification of CBD as a Schedule I Drug. This ruling could lead to problems for CBD merchants, who are marketing (in the eyes of the federal government) a substance on the same level of illegality as cocaine and heroin.
However, hope is not lost. As long as the status of CBD is in flux across the country (in terms of state vs. federal classifications, and the difference between hemp vs. marijuana CBD extracts), there are solutions out there for your business.